However, comprehensive long-term safety data remains limited, particularly regarding extended use over months or years
In a clinical trial including 2,605 people with heart failure but no prior history of diabetes, dapagliflozin (10 mg daily) led to a 32% reduction in new diabetes incidence over a median follow-up of 18 months (Barbarawi 2021
More specifically, it may interact with N-methyl-D-aspartate (NMDA) receptors, gamma-aminobutyric acid (GABA) receptors, and alpha 1-adrenergic receptors in the central nervous system [1, 2]
Blood work isn't always required before your first injection, but it gives us a clear picture of exactly where your levels stand
I will always recommend this office and Dr Zubair to friends and family